Sources | Names Used |
---|---|
CTRPv2 | BRD-K11533227 |
PharmacoGx | BRD-K11533227 |
Database | Identifier |
---|---|
Smiles: | -666 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HLA-DRA | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
mRNA | DHX32 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
mRNA | ESRRG | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | LYSMD2 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
mRNA | TFE3 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
mRNA | C16orf54 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
mRNA | FMR1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | SLCO1C1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
mRNA | MED12L | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | SLC25A12 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |